Effect and safety of oral Chinese patent medicine for heart failure: A protocol for systematic review and network meta-analysis

BACKGROUND: Heart failure (HF) is the terminal stage of various common cardiovascular diseases with quite a frequent readmission and a high mortality rate, and brings heavy financial burdens to families and society. Oral Chinese patent medicine (CPM) has been widely applied in the treatment of HF in...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Hui, Dai, Guohua, Wang, Ning, Gao, Wulin, Ren, Lili, Cai, Zhenhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571918/
https://www.ncbi.nlm.nih.gov/pubmed/33080741
http://dx.doi.org/10.1097/MD.0000000000022754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571918/
https://www.ncbi.nlm.nih.gov/pubmed/33080741
http://dx.doi.org/10.1097/MD.0000000000022754

Ejemplares similares